Cargando…

Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats

BACKGROUND: High dietary intake of selenium or isoflavones reduces risk factors for prostate cancer. We tested whether combined supplementation of these two dietary components would reduce prostate cancer risk factors in rats more than supplementation of each component individually. METHODS: Male No...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolman, Jessica R, Lephart, Edwin D, Setchell, Kenneth DR, Eggett, Dennis L, Christensen, Merrill J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615019/
https://www.ncbi.nlm.nih.gov/pubmed/19000315
http://dx.doi.org/10.1186/1743-7075-5-31
_version_ 1782163275046191104
author Tolman, Jessica R
Lephart, Edwin D
Setchell, Kenneth DR
Eggett, Dennis L
Christensen, Merrill J
author_facet Tolman, Jessica R
Lephart, Edwin D
Setchell, Kenneth DR
Eggett, Dennis L
Christensen, Merrill J
author_sort Tolman, Jessica R
collection PubMed
description BACKGROUND: High dietary intake of selenium or isoflavones reduces risk factors for prostate cancer. We tested whether combined supplementation of these two dietary components would reduce prostate cancer risk factors in rats more than supplementation of each component individually. METHODS: Male Noble rat pups were exposed from conception to diets containing an adequate (0.33–0.45 mg/kg diet) or high (3.33–3.45 mg/kg) concentration of selenium as Se-methylselenocysteine and a low (10 mg/kg) or high (600 mg/kg) level of isoflavones in a 2 × 2 factorial design. Pups consumed their respective diets until sacrifice at 35, 100, or 200 days. Male Noble rat breeders, whose exposure to the diets began after puberty, were sacrificed at 336 days. Rats were weighed biweekly. Blood was collected at the time of sacrifice and body fat and prostates were dissected and weighed. Serum levels of leptin, IGF-1, and testosterone were determined using ELISA kits. Serum levels of isoflavones were assayed by GC/MS. Liver activity of selenium-dependent glutathione peroxidase 1 was measured as an indicator of selenium status. RESULTS: Serum isoflavone concentrations were nearly 100-fold higher at 35 days of age (1187.1 vs. 14.4 ng/mL, mean ± SD) in pups fed the high vs. low isoflavone diets, and remained so at 100 and 200 days, and in breeders. There were no dietary differences in liver glutathione peroxidase activity in pups or breeders. High isoflavone intake significantly (p = 0.001–0.047) reduced body weight in rat pups from 35 days onward, but not in breeders. Body fat and leptin were likewise significantly reduced by high isoflavones in pups while effects in breeders were less pronounced but still significant. High intake of Se and isoflavones each decreased serum IGF-1 in pups at 100 and 200 days, but not in breeders. No consistent dietary effects were observed on serum testosterone or relative weights of prostates. In pups, the combination of high isoflavones and high selenium produced the lowest weight gain, the lowest serum leptin, and the lowest serum IGF-1 concentrations of all four diets. CONCLUSION: Combined intake of high selenium and high isoflavones may achieve greater chemopreventive effects than either compound individually. The timing of supplementation may determine the significance of its effects.
format Text
id pubmed-2615019
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26150192009-01-08 Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats Tolman, Jessica R Lephart, Edwin D Setchell, Kenneth DR Eggett, Dennis L Christensen, Merrill J Nutr Metab (Lond) Research BACKGROUND: High dietary intake of selenium or isoflavones reduces risk factors for prostate cancer. We tested whether combined supplementation of these two dietary components would reduce prostate cancer risk factors in rats more than supplementation of each component individually. METHODS: Male Noble rat pups were exposed from conception to diets containing an adequate (0.33–0.45 mg/kg diet) or high (3.33–3.45 mg/kg) concentration of selenium as Se-methylselenocysteine and a low (10 mg/kg) or high (600 mg/kg) level of isoflavones in a 2 × 2 factorial design. Pups consumed their respective diets until sacrifice at 35, 100, or 200 days. Male Noble rat breeders, whose exposure to the diets began after puberty, were sacrificed at 336 days. Rats were weighed biweekly. Blood was collected at the time of sacrifice and body fat and prostates were dissected and weighed. Serum levels of leptin, IGF-1, and testosterone were determined using ELISA kits. Serum levels of isoflavones were assayed by GC/MS. Liver activity of selenium-dependent glutathione peroxidase 1 was measured as an indicator of selenium status. RESULTS: Serum isoflavone concentrations were nearly 100-fold higher at 35 days of age (1187.1 vs. 14.4 ng/mL, mean ± SD) in pups fed the high vs. low isoflavone diets, and remained so at 100 and 200 days, and in breeders. There were no dietary differences in liver glutathione peroxidase activity in pups or breeders. High isoflavone intake significantly (p = 0.001–0.047) reduced body weight in rat pups from 35 days onward, but not in breeders. Body fat and leptin were likewise significantly reduced by high isoflavones in pups while effects in breeders were less pronounced but still significant. High intake of Se and isoflavones each decreased serum IGF-1 in pups at 100 and 200 days, but not in breeders. No consistent dietary effects were observed on serum testosterone or relative weights of prostates. In pups, the combination of high isoflavones and high selenium produced the lowest weight gain, the lowest serum leptin, and the lowest serum IGF-1 concentrations of all four diets. CONCLUSION: Combined intake of high selenium and high isoflavones may achieve greater chemopreventive effects than either compound individually. The timing of supplementation may determine the significance of its effects. BioMed Central 2008-11-10 /pmc/articles/PMC2615019/ /pubmed/19000315 http://dx.doi.org/10.1186/1743-7075-5-31 Text en Copyright © 2008 Tolman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tolman, Jessica R
Lephart, Edwin D
Setchell, Kenneth DR
Eggett, Dennis L
Christensen, Merrill J
Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title_full Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title_fullStr Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title_full_unstemmed Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title_short Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
title_sort timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615019/
https://www.ncbi.nlm.nih.gov/pubmed/19000315
http://dx.doi.org/10.1186/1743-7075-5-31
work_keys_str_mv AT tolmanjessicar timingofsupplementationofseleniumandisoflavonesdeterminesprostatecancerriskfactorreductioninrats
AT lephartedwind timingofsupplementationofseleniumandisoflavonesdeterminesprostatecancerriskfactorreductioninrats
AT setchellkennethdr timingofsupplementationofseleniumandisoflavonesdeterminesprostatecancerriskfactorreductioninrats
AT eggettdennisl timingofsupplementationofseleniumandisoflavonesdeterminesprostatecancerriskfactorreductioninrats
AT christensenmerrillj timingofsupplementationofseleniumandisoflavonesdeterminesprostatecancerriskfactorreductioninrats